Prolium Bioscience · New York startup hiring map by Fundable · PamPam
Prolium Bioscience
Prolium Bioscience is a NYC-based clinical-stage biotech developing a bispecific CD20xCD3 antibody therapy for systemic sclerosis and other severe autoimmune diseases.